Short Interest in DocMorris AG (OTCMKTS:ZRSEF) Declines By 47.2%

DocMorris AG (OTCMKTS:ZRSEF) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 460,930 shares, a decline of 47.2% from the April 15th total of 873,460 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ? days.

DocMorris Stock Performance

Shares of ZRSEF opened at $7.45 on Monday. The company has a 50-day moving average price of $7.45 and a two-hundred day moving average price of $8.30. DocMorris has a 12 month low of $7.45 and a 12 month high of $42.50.

DocMorris Company Profile

DocMorris is a leading European online pharmacy brand and a subsidiary of the Swiss-based Zur Rose Group (OTCMKTS:ZRSEF). Through its digital platform, the company offers mail-order dispensing of prescription medications and over-the-counter health products directly to consumers’ homes.

The company’s core services include the online sale and delivery of prescription and non-prescription drugs, health supplements, personal care items and medical devices. Leveraging its e-commerce infrastructure and proprietary pharmacy management systems, DocMorris also provides digital health solutions such as telemedicine consultations, medication management tools and mobile app-based healthcare services.

Originally launched in the early 2000s in Germany, DocMorris has expanded its reach to serve customers in multiple European countries, including the Netherlands, Belgium, Luxembourg and Switzerland.